Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse

Journal of Clinical Oncology

Volumn 28, Issue 15, 2010, Pages 2591-2597

  Ehlers, Stephanie ^a   Herbst, Christin ^a   Zimmermann, Martin ^a   Scharn, Nicole ^a   Germeshausen, Manuela ^a   Von Neuhoff, Nils ^a   Zwaan, Christian Michel ^a   Reinhardt, Katarina ^a   Hollink, Iris H ^a   Klusmann, Jan Henning ^a   Lehrnbecher, Thomas ^a   Roettgers, Silja ^a   Stary, Jan ^a   Dworzak, Michael ^a   Welte, Karl ^a   Creutzig, Ursula ^a   Reinhardt, Dirk ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; ISOPROTEIN; RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOGENETICS; EVENT FREE SURVIVAL; FEMALE; GENE MUTATION; GERMANY; HUMAN; HUMAN TISSUE; MALE; MORBIDITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCHOOL CHILD; TREATMENT OUTCOME; ADOLESCENT; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENETICS; INCIDENCE; METABOLISM; PHASE 3 CLINICAL TRIAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; MALE; PROSPECTIVE STUDIES; PROTEIN ISOFORMS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECURRENCE; TREATMENT OUTCOME;

EID: 77956400792     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.9010     Document Type: Article

References (38)

1. Alonzo TA, Kobrinsky NL, Aledo A, et al: Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 24:627-635, 2002 (Pubitemid 35285101)
2. Creutzig U, Zimmermann M, Lehrnbecher T, et al: Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98. J Clin Oncol 24:4499-4506, 2006 (Pubitemid 46646248)
3. Lehrnbecher T, Zimmermann M, Reinhardt D, et al: Prophylactic human granulocyte colonystimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 109:936-943, 2007 (Pubitemid 46220636)
4. Germeshausen M, Ballmaier M, Welte K: Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 109:93-99, 2007 (Pubitemid 46053048)
5. Sloand EM, Yong AS, Ramkissoon S, et al: Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A 103:14483-14488, 2006 (Pubitemid 44484776)
6. Beillard E, Pallisgaard N, van der Velden VH, et al: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reversetranscriptase polymerase chain reaction (RQ-PCR): A Europe against cancer program. Leukemia 17: 2474-2486, 2003
7. Cheson BD, Cassileth PA, Head DR, et al: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813-819, 1990 (Pubitemid 20148273)
8. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al: The analysis of failure times in the presence of competing risks. Biometrics 34:541-554, 1978 (Pubitemid 9067879)
9. Langebrake C, Creutzig U, Dworzak M, et al: Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: The MRD-AML-BFM Study Group. J Clin Oncol 24:3686-3692, 2006 (Pubitemid 46630545)
10. Viehmann S, Teigler-Schlegel A, Bruch J, et al: Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQRT- PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement. Leukemia 17:1130-1136, 2003 (Pubitemid 36722244)
11. Scharn N, Ballmaier M, Reinhardt K, et al: CSF3R mutations in paediatric acute myeloid leukaemia. Br J Haematol 144:140-142, 2009
12. Creutzig U, Zimmermann M, Reinhardt D, et al: Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 22:4384-4393, 2004 (Pubitemid 41185159)
13. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78:2791-2808, 1991
14. White SM, Ball ED, Ehmann WC, et al: Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia 12:899-906, 1998 (Pubitemid 28287213)
15. White SM, Alarcon MH, Tweardy DJ: Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform. Blood 95:3335-3340, 2000 (Pubitemid 30428461)
16. Dong F, van Buitenen C, Pouwels K, et al: Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13:7774-7781, 1993 (Pubitemid 23354302)
17. Avalos BR: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88: 761-777, 1996
18. Avalos BR: The granulocyte colony-stimulating factor receptor and its role in disorders of granulopoiesis. Leuk Lymphoma 28:265-273, 1998
19. Dong F, Brynes RK, Tidow N, et al: Mutations in the gene for the granulocyte colony-stimulatingfactor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333:487-493, 1995
20. Dong F, Dale DC, Bonilla MA, et al: Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11:120-125, 1997 (Pubitemid 27065058)
21. Dong F, Hoefsloot LH, Schelen AM, et al: Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A 91:4480-4484, 1994
22. Hunter MG, Avalos BR: Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 160:4979-4987, 1998 (Pubitemid 28215333)
23. Hunter MG, Avalos BR: Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 95:2132-2137, 2000 (Pubitemid 30151656)
24. Hunter MG, Jacob A, O'donnell LC, et al: Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/ acute myelogenous leukemia. J Immunol 173:5036-5045, 2004 (Pubitemid 39387786)
25. Dong F, Qiu Y, Yi T, et al: The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol 167:6447-6452, 2001 (Pubitemid 33081578)
26. Gits J, van Leeuwen D, Carroll HP, et al: Multiple pathways contribute to the hyperproliferative responses from truncated granulocyte colony-stimulating factor receptors. Leukemia 20:2111-2118, 2006 (Pubitemid 44782836)
27. Richards MK, Liu F, Iwasaki H, et al: The use of a competitive repopulation assay to investigate G-CSF receptor signals in hematopoiesis. Blood 100:506a, 2002 (suppl; abstr 1974)
28. Irandoust MI, Aarts LH, Roovers O, et al: Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J 26:1782-1793, 2007 (Pubitemid 46624051)
29. Kindwall-Keller TL, Druhan LJ, Ai J, et al: Role of the proteasome in modulating native G-CSFR expression. Cytokine 43:114-123, 2008
30. van de Geijn GJ, Gits J, Aarts LH, et al: G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 104:667-674, 2004 (Pubitemid 38970559)
31. Zhuang D, Qiu Y, Haque SJ, et al: Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: Involvement of SOCS3 and SOCS1. J Leukoc Biol 78:1008-1015, 2005 (Pubitemid 41384418)
32. Lotem J, Sachs L: Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: Restoration of requirement for normal growthinducing protein without restoring induction of differentiation-inducing protein. Proc Natl Acad Sci U S A 79:4347-4351, 1982 (Pubitemid 12045791)
33. Souza LM, Boone TC, Gabrilove J, et al: Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61-65, 1986 (Pubitemid 16037976)
34. Vellenga E, Young DC, Wagner K, et al: The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 69:1771-1776, 1987 (Pubitemid 17091639)
35. Nara N, Murohashi I, Suzuki T, et al: Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients. Br J Cancer 56:49-51, 1987 (Pubitemid 17097697)
36. Begley CG, Metcalf D, Nicola NA: Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes. Exp Hematol 16:71-79, 1988 (Pubitemid 18079493)
37. Cheng GY, Kelleher CA, Miyauchi J, et al: Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood 71:204-208, 1988 (Pubitemid 18050412)
38. Young DC, Demetri GD, Ernst TJ, et al: In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. Exp Hematol 16:378-382, 1988